U.S. Patent 7651596 was awarded to DexCom, Inc. on 2010-01-26 and describes a “Cellulosic-based interference domain for an analyte sensor.” This patent has been cited 329 times by other U.S. patents which places it in the top 500 cited patents since 2010 according to our law firm research, and makes it of the most innovative medical technology patents in the field of instruments. The abstract states:

The present invention relates generally to devices for measuring an analyte in a host. More particularly, the present invention relates to devices for measurement of glucose in a host that incorporate a cellulosic-based interference domain. Link: U.S. Patent 7651596

This patent was originally filed on 2006-01-18 which gives it a processing time of 1469 days, compared to an average processing time of 1775 in the field. DexCom, Inc. has 423 total patents. The first named inventor is Robert J. Boock of Carlsbad, CA. The primary examiner was Alex Noguerola.

Select Patents monitors top medical technology patents and instruments patents which have been allowed and granted worldwide. If you would like legal advice regarding a patent or would like to file a patent go to https://selectpatents.wpengine.com/contact/